OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 73 filers reported holding OYSTER PT PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $66,185,456 | +98.8% | 5,925,287 | 0.0% | 3.72% | +123.8% |
| Q3 2022 | $33,300,000 | +29.8% | 5,925,287 | 0.0% | 1.66% | +26.1% |
| Q2 2022 | $25,656,000 | -62.8% | 5,925,287 | 0.0% | 1.32% | -33.8% |
| Q1 2022 | $68,970,000 | -36.3% | 5,925,287 | 0.0% | 1.99% | -8.9% |
| Q4 2021 | $108,196,000 | +54.1% | 5,925,287 | 0.0% | 2.19% | +162.2% |
| Q3 2021 | $70,215,000 | -31.1% | 5,925,287 | 0.0% | 0.83% | -37.2% |
| Q2 2021 | $101,856,000 | -6.0% | 5,925,287 | 0.0% | 1.33% | -45.4% |
| Q1 2021 | $108,314,000 | -2.9% | 5,925,287 | 0.0% | 2.43% | -17.4% |
| Q4 2020 | $111,514,000 | -10.8% | 5,925,287 | 0.0% | 2.94% | -44.4% |
| Q3 2020 | $125,083,000 | -26.9% | 5,925,287 | 0.0% | 5.30% | -23.0% |
| Q2 2020 | $171,122,000 | -17.5% | 5,925,287 | 0.0% | 6.88% | -36.5% |
| Q1 2020 | $207,385,000 | +43.2% | 5,925,287 | 0.0% | 10.84% | +58.2% |
| Q4 2019 | $144,814,000 | – | 5,925,287 | – | 6.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |